A measured, harm-reduction look at enclomiphene, why it is used instead of exogenous testosterone, and the bloodwork that tells you whether it is working.
At a glance
Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM). Clomiphene is a mixture of two isomers - enclomiphene (trans) and zuclomiphene (cis) - and the trans-isomer is the shorter-acting, more purely estrogen-antagonist fraction. Isolating it has made enclomiphene the dominant fertility-preserving alternative to testosterone replacement, because it raises your own testosterone rather than replacing it.
This is an educational tracking guide, not medical advice or a recommendation. Enclomiphene is a prescription drug in many places and is discussed here for people already using it under supervision.
Enclomiphene is taken orally, commonly daily or every other day, with doses described in research literature as low single-digit to low double-digit milligram ranges. It is used both as an ongoing TRT-alternative for men who want to keep fertility and as part of post-cycle therapy to restart the axis. Ranges here are informational only; dosing belongs with a physician.
For many men enclomiphene brings testosterone into a healthy range within a few weeks while keeping the testes online. It is not a mass-building drug and it will not produce supraphysiological testosterone the way injectable esters can. If your pituitary or testes are the problem rather than the signal, it may do little - it needs a working axis to push on.
Enclomiphene is a prescription medication with real, if generally mild, risks: mood changes, visual disturbances, and shifts in lipids and estradiol. Long-term human safety data are still limited compared with established TRT. It should be used with physician oversight and periodic bloodwork, and any visual symptoms are a reason to stop and seek review.
Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.